Skip to main content

Apellis Pharmaceuticals' stock offering closes $50M higher than expected

The former Louisville-area company sold about 1.4 million more shares that were part of an option held by financial firms involved with the public stock offering.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.